UK-based biopharmaceuticals producer Mallinckrodt has agreed to sell is CDMO subsidiary BioVectra to HIG Capital, a private equity firm.
Cambrex has signed a definitive agreement to be acquired by an affiliate of private equity firm Permira, which has $48 billion of committed capital in its portfolio, covering healthcare among four other sectors.
Onyx Scientific has revealed that it has been engaging with the UK Medicines & Healthcare Products Regulatory Agency (MHRA) with a view to securing a commercial API licence by the end of 2019.
Belgian CDMO Ardena has launched Ardena LSI, which it describes as “a new business arm dedicated to the sale of chemical ingredients and intermediates for the life science industry”.
Swiss fine chemicals firm RohnerChem announced on 24 June 2019 that it is ceasing operations after 113 years.
US-based API manufacturer Ampac Fine Chemicals (AFC) has officially reopened the manufacturing operations of its AFC-Virginia facility in front of state and local dignitaries and other guests.
Seqens has officially opened its main innovation and development (I&D) centre called Seqens’Lab at Porcheville with a ribbon-cutting ceremony performed by Agnès Pannier-Runacher, secretary of state to the Minister of Economy & Finance.